Overview

A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease

Status:
Completed

Trial end date:
2010-07-05

Target enrollment:

Participant gender:

Summary

The purpose of the study is to evaluate the safety of PF-04447943 when given in combination with donepezil in subjects who have Alzheimer's Disease. The study will also evaluate the absorption and distribution of both PF-04447943 and donepezil.

Phase:

Phase 1

Details

Lead Sponsor:

Pfizer

Treatments:

Donepezil